Table 1.
NP | NP + Inf-4 | FXII def. | FXI def. | NP + ASIS | NP + Inf-4 + ASIS | |
---|---|---|---|---|---|---|
Lag time (min) | 10.7 ± 1.0 | 22.0 ± 3.7* | 16.0 ± 2.5† | 21.0 ± 2.0* | 20.6 ± 1.9‡ | NA |
Time to peak (min) | 15.2 ± 1.1 | 30.1 ± 5.0‡ | 25.3 ± 2.7‡ | 27.9 ± 2.1‡ | 33.3 ± 4.1‡ | NA |
Peak thrombin (nM) | 191.1 ± 16.0 | 109.4 ± 31.3* | 94.3 ± 20.1‡ | 41.6 ± 14.5‡ | 51.9 ± 12.8‡ | NA |
ETP (nM⋅min) | 1622 ± 59 | 998 ± 267† | 1098 ± 186† | 568 ± 176‡ | 686 ± 157‡ | NA |
Comparison of PC3 prostasome-induced thrombin formation in platelet free normal plasma (NP), NP supplemented with rHA-Infestin-4 (Inf-4; 500 µg/mL), ASIS (30 nM), or a combination of ASIS and Inf-4 (30 nM and 500 µg/mL) and plasma deficient in FXII (FXII def.) or FXI (FXI def.) as done in Figure 2G-H. Values are expressed as mean ± SEM, n = 3 to 11. ETP, endogenous thrombin potential; NA, below the detection limit.
P < .01 vs buffer-treated NP, ANOVA.
P < .05 vs buffer-treated NP, ANOVA.
P < .001 vs buffer-treated NP, ANOVA.